Polish Investing Ideas

Global Weekly Picks

CA$5.25
FV
54.7% undervalued intrinsic discount
6.6k
users have viewed this narrative
24users have liked this narrative
0users have commented on this narrative
110users have followed this narrative
US$71.48
FV
59.0% undervalued intrinsic discount
56.00%
Revenue growth p.a.
15.7k
users have viewed this narrative
32users have liked this narrative
8users have commented on this narrative
213users have followed this narrative
zł41.18
48.8% undervalued intrinsic discount
Fair Value
Profit Margin
15.31%
Future PE
24.26x
Price in 2030
zł64.25
zł822.19
20.9% undervalued intrinsic discount
Set with the author's own calculation method
zł330
118.5% overvalued intrinsic discount
Fair Value
Revenue
3.12% p.a.
Profit Margin
8%
Future PE
15x
Price in 2029
zł510.7
zł293.45
18.0% undervalued intrinsic discount
Fair Value
Revenue
9% p.a.
Profit Margin
50%
Future PE
13x
Price in 2030
zł472.61
SNT logo
Synektik Spólka Akcyjna

Cardiac marker could be a hit

In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more

View narrative
zł204.19
75.5% overvalued intrinsic discount
Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79
zł100.96
34.6% overvalued intrinsic discount
Fair Value
Revenue
15% p.a.
Profit Margin
46%
Future PE
12x
Price in 2028
zł133.69